Federal Health Agency to Ditch Birth Vaccination for Hepatitis B Amid COVID-19 Concerns - A move that public health experts warn could leave pregnant women and children vulnerable to infection has been approved by the Advisory Committee on Immunization Practices (ACIP).
The ACIP voted 8-3 to delay administering the first dose of hepatitis B vaccine until 30 days after birth, a change that has sparked concern among medical professionals. The shift in recommendation comes amid growing controversy over vaccine efficacy and safety, fueled in part by misinformation about COVID-19 vaccines being shared by high-profile figures.
Experts warn that the change could lead to reduced access to vaccines for children and pregnant women, particularly those from low-income backgrounds or with limited healthcare access. Dr. Susan J. Kressly of the American Academy of Pediatrics (AAP) expressed alarm over the move, stating that there is no new information about hepatitis B vaccine safety prompting the change.
Critics argue that by relying on pregnant individuals to determine whether their newborn receives a timely dose of the vaccine, they are shouldering an undue burden and risking infection. Dr. Raynard Washington of the Big Cities Health Coalition noted that "putting that responsibility on pregnant people β having to determine whether or not to give their newborn the dose right after birth or wait 30 days β would be completely irresponsible."
Public health experts point out that the current vaccination process has proven effective, with a 99% drop in severe hepatitis B infections since its introduction. They also highlight the risks associated with delaying vaccine administration, which can leave children susceptible to infection.
The move has been met with skepticism by medical professionals and public health advocates, who warn of devastating consequences for children's health and overall public well-being. Dr. Sean O'Leary of the AAP Committee on Infectious Diseases stated that "there's no reason to delay or space out vaccines," emphasizing the importance of the current vaccination schedule.
The shift in recommendation is part of a broader effort by RFK Jr., a prominent advocate for vaccine reform, to overhaul the US immunization system. The move has sparked controversy, with many experts questioning Kennedy's motivations and the scientific merit of his proposals.
The ACIP voted 8-3 to delay administering the first dose of hepatitis B vaccine until 30 days after birth, a change that has sparked concern among medical professionals. The shift in recommendation comes amid growing controversy over vaccine efficacy and safety, fueled in part by misinformation about COVID-19 vaccines being shared by high-profile figures.
Experts warn that the change could lead to reduced access to vaccines for children and pregnant women, particularly those from low-income backgrounds or with limited healthcare access. Dr. Susan J. Kressly of the American Academy of Pediatrics (AAP) expressed alarm over the move, stating that there is no new information about hepatitis B vaccine safety prompting the change.
Critics argue that by relying on pregnant individuals to determine whether their newborn receives a timely dose of the vaccine, they are shouldering an undue burden and risking infection. Dr. Raynard Washington of the Big Cities Health Coalition noted that "putting that responsibility on pregnant people β having to determine whether or not to give their newborn the dose right after birth or wait 30 days β would be completely irresponsible."
Public health experts point out that the current vaccination process has proven effective, with a 99% drop in severe hepatitis B infections since its introduction. They also highlight the risks associated with delaying vaccine administration, which can leave children susceptible to infection.
The move has been met with skepticism by medical professionals and public health advocates, who warn of devastating consequences for children's health and overall public well-being. Dr. Sean O'Leary of the AAP Committee on Infectious Diseases stated that "there's no reason to delay or space out vaccines," emphasizing the importance of the current vaccination schedule.
The shift in recommendation is part of a broader effort by RFK Jr., a prominent advocate for vaccine reform, to overhaul the US immunization system. The move has sparked controversy, with many experts questioning Kennedy's motivations and the scientific merit of his proposals.